Spot the Early Signs Education Program

Early diagnosis can make a difference

The program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients. Following a Peer2Peer educational approach, the program targets to improve everyday practice and the way child healthcare professions advise and treat the children and families they support. Pediatricians and family doctors are likely to be the first healthcare professionals to observe symptoms, and it is important to help these front-line clinicians suspect, diagnose, and refer patients.

All webinars are free-to-view and a certificate of attendance will be provided by the EIP Institute for those who attend a session.

     
     
   
     
 

Avoiding Misdiagnosis of Mucopolysaccharidoses (MPS) 

 
     
  Misdiagnosis of Mucopolysaccharidosis (MPS) results in late diagnosis and the late start of treatment, which has significant consequences on long-term outcomes. This gap usually results in confusing symptoms with other conditions, most notably trying to address symptoms directly and therefore delaying actual diagnosis and treatment, or referring the patient to the wrong pediatric specialties causing further delays in the condition’s management chain.  
     
 

23 webinars

 
   
     
     
     
     
     
     
   
     
 

Spot The Early Signs of Metachromatic Leukodystrophy (MLD)

 
     
 

Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer (myelin sheath) surrounding the nerves in both the central nervous system and the peripheral nervous system, ultimately affecting intellectual and motor function.

Early-onset clinical manifestations are often overlooked or confused with other conditions causing confusion among non-trained HCPs at first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in starting treatment have significant consequences on the conditions’ development, and the patient’s health and quality of life. This delay in referral and treatment must be overcome.

The 4 webinars in the Series cover the basics of MLD, practical neurological case studies that offer the opportunity to connect the theory with the practice and treatment options.

 
     
 

4 webinars

 
   
     
     
     
 

The Spot The Early Signs Program is independently developed and managed by EiP in terms of content, topics and speakers appointed. Unrestricted grants are sought to support EIP activities and the companies below have provided unrestricted educational grants to partially support EIP's work on the misdiagnosis of rare diseases.